Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference
Semler Scientific, a leader in healthcare technology solutions, announced its participation in the 21st Annual Needham Virtual Healthcare Conference on April 13 at 1:30 pm ET. CEO Doug Murphy-Chutorian and CMO Dennis Rosenberg will present a company overview and engage in one-on-one calls with investors. A live webcast of the event will be available on the Semler Scientific website under the 'Events and Presentations' section, with an archived version accessible for 90 days post-conference. Semler's flagship product, QuantaFlo®, aids in diagnosing peripheral arterial disease.
- None.
- None.
SANTA CLARA, Calif., April 7, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian, and chief marketing officer, Dennis Rosenberg, will present a company overview at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, at 1:30 pm ET. Management will also participate in one-on-one calls with investors.
A live webcast will be available under "Events and Presentations" on the "Investor Info" section of the Semler Scientific website and may be accessed through the following link: https://wsw.com/webcast/needham117/smlr/2278090. The presentation will be archived for a period of 90 days after the conference.
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific's patented and U.S. Food and Drug Administration, or FDA, cleared product, QuantaFlo®, is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at www.semlerscientific.com.
CONTACT:
Susan A. Noonan
S.A. Noonan Communications
susan@sanoonan.com
917 513 5303
View original content:https://www.prnewswire.com/news-releases/semler-to-participate-in-the-21st-annual-needham-virtual-healthcare-conference-301519747.html
SOURCE Semler Scientific, Inc.
FAQ
What date will Semler Scientific present at the Needham Virtual Healthcare Conference?
Who will represent Semler Scientific at the Needham Conference?
How can I access the live webcast for Semler Scientific's presentation?
What is QuantaFlo® and its purpose?
How long will the webcast of Semler Scientific's presentation be available after the conference?
